References
- What you need to know about Diabetes. American Diabetes Association, Alexandria, VA. 1992
- Direct and Indirect costs of Diabetes in the United States in 1992. American Diabetes Association. Alexandria, VA. 1993
- Diabetes Facts. American Diabetes Association. Pennsylvania Affiliate, Inc. Plymouth Meeting, PA. 1993
- United States Renal Disease System 1993. Annual Report: The National Institute of Health, The National Institute of Diabetes, Digestive and Kidney. Diseases, Bethesda, MD, March, 1993, xvi, xvii, 7,9,10,13,14,H-5
- Mauer S. M., Chavers B. M. A comparison of kidney disease in type I and II diabetes. Adv Exp Med Biol 1989; 189: 299–303
- Jensen T., Borch-Johnsen K., Kofoed-Enevoldsen A. Dreekert coronary heart disease in young type I diabetics with and without diabetic nephropathy. Incidence and risk factors: Diabetologia 1987; 30: 144–8
- Friis T., Pedersen L. R. Microalbuminuria in type II diabetic patients; a prospective follow up study. Ann Clin Biochem. 1997; 34: 247–51
- Hasslacher C. Diabetic nephropathy: diagnosis and therapy: Ther. Umsch (German) 1996; 53(12)943–7
- Epstein M., Sowers J. R. Diabetes mellitus and. Hypertension 1992; 19: 403–418
- Parving H. H., Tarnow L., Rossing P. Renal protection in diabetes: an emerging role for calcium antagonists. J Hypertens-suppl 1996; 14(4)521–5
- Tuttle K. R., Defronzo R. A., Stein J. H. Treatment of diabetic nephropathy, a rational approach based on its pathophysiology. Semin Nephrol 1991; 11: 220–235
- Breyer J. A. Diabetes nephropathy in insulin — dependent patients. Am J Kidney Dis 1992; 20: 533–547
- Anderson S., Brenner B. M. Pathogenesis of diabetic glomerulopathy, hemodynamic concentration. Diabetes Metab Rev 1998; 4: 163–177
- Hostetter T. H., Rennke H. G., Brenner B. M. The case for intrarenal hypertension in the initiation and progression of diabetic and other gromerulopathies. Am J Med 1982; 72: 375–380
- Gosling P. Microalbuminuria. A marker of systemic disease. J App Med 1996; 53
- Cramer K., Christensen C. K. The pre-proteinuric phase of diabetic nephropathy. Danish Medic Bulletin 1991; 38(2)145
- Mongensen C. E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl T Med 1984; 310: 356–60
- Gosling P., Sanghera K., Dickson G. Generalized vascularpermeability and pulmonary function in patients following serious trauma. J Trauma 1994; 36: 1–5
- Fleck A., Raines G., Hawker R, et al. Increased vascular permeability a major cause of hypoalbuminuria in disease and injury. Lancet 1985; 1: 781–3
- Sheth J., Trivedi B. B., Shah L. J. Prevalence of microalbuminuria in diabetic subjects. J Assoc Phy Ind 1990; 41: 9
- Brier J. A. Diabetic nephropathy in insulin-dependent patients. Am J Kidnev Dis 1992; 20: 533–547
- Mogenson C. E., Christensers C. K., Vittinghus E. The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. diabetes 1983; 31(Suppl 2)64–78
- A Multicenter Study. United Kingdom Prospective Diabetes Study. Hypertension 1985; 7: 118
- Morales P. A., Braxton D. M., Valdez R. A., et al. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. Diabetes 1993; 42: 154
- DeChatel R., Toth M., Barna I. Exchangeable body selium. Its relationship with blood pressure and atrial natriuretic factor in patients with diabetes mellitus. J Hyperten 1986; 4(suppl 6)526
- Berchtold P., Jorgen V., Finke C., et al. Epidemiology of obesity and hypertension. Int J Obe 1981; 5(suppl 1)1
- Sheth J., Trivedi B. B. Effect of enalapril on microalbuminuria and blood pressure. Ind J Clin Prac 1992; 2(10)45